UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL DATAUnaudited Pro Forma Condensed Combined Financial Data • January 21st, 2020 • Elanco Animal Health Inc • Pharmaceutical preparations
On August 20, 2019, Elanco Animal Health Incorporated (“Elanco,” “our” or “we”) and Bayer Aktiengesellschaft (“Bayer”) entered into the Share and Asset Purchase Agreement (the “Purchase Agreement”), pursuant to which Elanco agreed to purchase Bayer’s animal health business (the “Bayer Animal Health Business”) in exchange for cash and Elanco shares (the “Acquisition”). The unaudited pro forma condensed combined financial data set forth below gives effect to the following:
